- Home
- KRON vs BUJA Comparison
KRON vs BUJA Comparison
Compare KRON & BUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- BUJA
- Stock Information
- Founded
- KRON 2017
- BUJA 2022
- Country
- KRON United States
- BUJA Malaysia
- Employees
- KRON N/A
- BUJA N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- BUJA Blank Checks
- Sector
- KRON Health Care
- BUJA Finance
- Exchange
- KRON Nasdaq
- BUJA Nasdaq
- Market Cap
- KRON 60.3M
- BUJA 55.2M
- IPO Year
- KRON 2020
- BUJA 2023
- Fundamental
- Price
- KRON $0.97
- BUJA $11.20
- Analyst Decision
- KRON Buy
- BUJA
- Analyst Count
- KRON 3
- BUJA 0
- Target Price
- KRON $1.63
- BUJA N/A
- AVG Volume (30 Days)
- KRON 384.9K
- BUJA 14.2K
- Earning Date
- KRON 11-13-2024
- BUJA 01-01-0001
- Dividend Yield
- KRON N/A
- BUJA N/A
- EPS Growth
- KRON N/A
- BUJA N/A
- EPS
- KRON N/A
- BUJA 0.25
- Revenue
- KRON $9,864,000.00
- BUJA N/A
- Revenue This Year
- KRON $62.21
- BUJA N/A
- Revenue Next Year
- KRON N/A
- BUJA N/A
- P/E Ratio
- KRON N/A
- BUJA $44.25
- Revenue Growth
- KRON 146.48
- BUJA N/A
- 52 Week Low
- KRON $0.69
- BUJA $10.37
- 52 Week High
- KRON $1.60
- BUJA $12.18
- Technical
- Relative Strength Index (RSI)
- KRON 52.82
- BUJA 93.47
- Support Level
- KRON $0.92
- BUJA $10.95
- Resistance Level
- KRON $1.03
- BUJA $11.18
- Average True Range (ATR)
- KRON 0.06
- BUJA 0.00
- MACD
- KRON -0.00
- BUJA 0.00
- Stochastic Oscillator
- KRON 44.16
- BUJA 100.00
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
About BUJA Bukit Jalil Global Acquisition 1 Ltd.
Bukit Jalil Global Acquisition 1 Ltd is a blank check company.